Literature DB >> 25469012

Toll-like receptor-mediated signaling cascade as a regulator of the inflammation network during alcoholic liver disease.

Sara Ceccarelli1, Valerio Nobili1, Anna Alisi1.   

Abstract

Chronic abuse of alcohol leads to various histological abnormalities in the liver. These are conditions collectively known as alcoholic liver disease (ALD). Currently, ALD is considered to be one of the major causes of death worldwide. An impaired intestinal barrier with related endotoxemia is among the various pathogenetic factors. This is mainly characterized by circulating levels of lipopolysaccharide (LPS), considered critical for the onset of intra-hepatic inflammation. This in turn promotes hepatocellular damage and fibrosis in ALD. Elevated levels of LPS exert their effects by binding to Toll-like receptors (TLRs) which are expressed by all liver-resident cells. The activation of TLR signaling triggers an overproduction and release of some cytokines, which promote an autocatalytic cascade of other pro-inflammatory signals. In this review, we provide an overview of the mechanisms that sustain LPS-mediated activation of TLR signaling, reporting current experimental and clinical evidence of its role during inflammation in ALD.

Entities:  

Keywords:  Alcoholic liver disease; Cirrhosis; Cytokines; Inflammation; Nuclear factor-κB; Toll-like receptors

Mesh:

Substances:

Year:  2014        PMID: 25469012      PMCID: PMC4248187          DOI: 10.3748/wjg.v20.i44.16443

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  78 in total

Review 1.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

Review 2.  Alcoholic liver disease.

Authors:  Robert S O'Shea; Srinivasan Dasarathy; Arthur J McCullough
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

3.  Association between CD14-159C>T polymorphisms and the risk for alcoholic liver disease: a meta-analysis.

Authors:  Tao Zeng; Cui-Li Zhang; Xiao-Ying Han; Sheng Zhao; Ke-Qin Xie
Journal:  Eur J Gastroenterol Hepatol       Date:  2013-10       Impact factor: 2.566

4.  NFkappaB, cytokines, TLR 3 and 7 expression in human end-stage HCV and alcoholic liver disease.

Authors:  Peter Stärkel; Christine De Saeger; Alastair J Strain; Isabelle Leclercq; Yves Horsmans
Journal:  Eur J Clin Invest       Date:  2010-07       Impact factor: 4.686

5.  Kupffer cell-derived prostaglandin E(2) is involved in alcohol-induced fat accumulation in rat liver.

Authors:  N Enomoto; K Ikejima; S Yamashina; A Enomoto; T Nishiura; T Nishimura; D A Brenner; P Schemmer; B U Bradford; C A Rivera; Z Zhong; R G Thurman
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-07       Impact factor: 4.052

6.  Ethanol and dietary unsaturated fat (corn oil/linoleic acid enriched) cause intestinal inflammation and impaired intestinal barrier defense in mice chronically fed alcohol.

Authors:  Irina A Kirpich; Wenke Feng; Yuhua Wang; Yanlong Liu; Juliane I Beier; Gavin E Arteel; K Cameron Falkner; Shirish S Barve; Craig J McClain
Journal:  Alcohol       Date:  2013-02-26       Impact factor: 2.405

Review 7.  Recent Advances in Alcoholic Liver Disease I. Role of intestinal permeability and endotoxemia in alcoholic liver disease.

Authors:  R K Rao; A Seth; P Sheth
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-06       Impact factor: 4.052

8.  Increased immunoglobulin A in alcoholic liver cirrhosis: exploring the response of B cells to Toll-like receptor 9 activation.

Authors:  B Massonnet; A Delwail; J-M Ayrault; C Chagneau-Derrode; J-C Lecron; C Silvain
Journal:  Clin Exp Immunol       Date:  2009-10       Impact factor: 4.330

Review 9.  Molecular mechanisms of alcoholic fatty liver.

Authors:  Vishnudutt Purohit; Bin Gao; Byoung-Joon Song
Journal:  Alcohol Clin Exp Res       Date:  2008-11-19       Impact factor: 3.455

Review 10.  Changes in the pathogenesis of alcohol-induced liver disease -- preclinical studies.

Authors:  Manuela G Neuman; Samuel W French; Carol A Casey; Kusum K Kharbanda; Radu M Nanau; Karuna Rasineni; Benita L McVicker; Vincent Kong; Terrence M Donohue
Journal:  Exp Mol Pathol       Date:  2013-10-23       Impact factor: 3.362

View more
  15 in total

Review 1.  Alcoholic liver disease: a new insight into the pathogenesis of liver disease.

Authors:  Seol Hee Park; Young-Sun Lee; Jaemin Sim; Seonkyung Seo; Wonhyo Seo
Journal:  Arch Pharm Res       Date:  2022-06-27       Impact factor: 6.010

2.  Exercise Training and Probiotic Lacticaseibacillus rhamnosus GG Reduce Tetracycline-Induced Liver Oxidative Stress and Inflammation in Rats with Hepatic Steatosis.

Authors:  Fariba Aghaei; Ehsan Arabzadeh; Hamideh Mahmoodzadeh Hosseini; Hossein Shirvani
Journal:  Probiotics Antimicrob Proteins       Date:  2022-09-28       Impact factor: 5.265

Review 3.  Role of cAMP and phosphodiesterase signaling in liver health and disease.

Authors:  Banrida Wahlang; Craig McClain; Shirish Barve; Leila Gobejishvili
Journal:  Cell Signal       Date:  2018-06-11       Impact factor: 4.315

Review 4.  Inflammatory status in human hepatic cirrhosis.

Authors:  María Martínez-Esparza; María Tristán-Manzano; Antonio J Ruiz-Alcaraz; Pilar García-Peñarrubia
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

5.  Natural small molecule FMHM inhibits lipopolysaccharide-induced inflammatory response by promoting TRAF6 degradation via K48-linked polyubiquitination.

Authors:  Ke-Wu Zeng; Li-Xi Liao; Hai-Ning Lv; Fang-Jiao Song; Qian Yu; Xin Dong; Jun Li; Yong Jiang; Peng-Fei Tu
Journal:  Sci Rep       Date:  2015-10-01       Impact factor: 4.379

6.  Protective Effect of the Total Saponins from Rosa laevigata Michx Fruit against Carbon Tetrachloride-Induced Liver Fibrosis in Rats.

Authors:  Deshi Dong; Lianhong Yin; Yan Qi; Lina Xu; Jinyong Peng
Journal:  Nutrients       Date:  2015-06-15       Impact factor: 5.717

7.  Increased Abundance of Plasmacytoid Dendritic Cells and Interferon-Alpha Induces Plasma Cell Differentiation in Patients of IgA Nephropathy.

Authors:  Nuoyan Zheng; Bing Wang; Jinjin Fan; Ning Luo; Qingyu Kong; Hongjian Ye; Jiqin Zhang; Hongyan Ming; Xueqing Yu
Journal:  Mediators Inflamm       Date:  2017-12-18       Impact factor: 4.711

Review 8.  Alcoholic Liver Disease: Role of Cytokines.

Authors:  Manuela G Neuman; Yaakov Maor; Radu M Nanau; Ehud Melzer; Haim Mell; Mihai Opris; Lawrence Cohen; Stephen Malnick
Journal:  Biomolecules       Date:  2015-08-28

9.  LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease.

Authors:  Sara Ceccarelli; Nadia Panera; Marco Mina; Daniela Gnani; Cristiano De Stefanis; Annalisa Crudele; Chiara Rychlicki; Stefania Petrini; Giovannella Bruscalupi; Laura Agostinelli; Laura Stronati; Salvatore Cucchiara; Giovanni Musso; Cesare Furlanello; Gianluca Svegliati-Baroni; Valerio Nobili; Anna Alisi
Journal:  Oncotarget       Date:  2015-12-08

10.  Resveratrol Ameliorates Experimental Alcoholic Liver Disease by Modulating Oxidative Stress.

Authors:  He Peiyuan; Hou Zhiping; Song Chengjun; Wang Chunqing; Li Bingqing; Mustapha Umar Imam
Journal:  Evid Based Complement Alternat Med       Date:  2017-12-31       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.